Ixodes AG is a Swiss pharmaceutical company dedicated to improving patient lives through innovative technologies for the prevention of Lyme Disease.
Ixodes's first therapeutic product, the Ixogel® is a new solution to prevent Lyme Disease via a topical application of an antibiotic after a tick bite.

Home i About us i Ixogel® i Lyme disease i Medical need i News i Team i Contact